How Long Does Sperm Take to Reach the Egg? The Honest Biology

• The fastest sperm reach the egg in 30-45 minutes; most take several hours, and some released from cervical reservoirs take a day or more.
• Sperm survive up to 5 days in fertile egg-white cervical mucus, which is why the fertile window spans the 5 days before ovulation plus ovulation day.
• The egg lives only 12-24 hours after ovulation, so sperm already waiting (from intercourse in the days before) often conceive better than sperm arriving on ovulation day.
• Of 200-300 million sperm ejaculated, only a few hundred reach the egg; the female tract is a brutal selection filter at every stage.
• Sperm need several hours of capacitation before they can fertilise, so reaching the egg fast does not mean fertilising fast.
• Male factor accounts for roughly 40% of Indian fertility issues (ICMR), so evaluate both partners together, not the woman first.

The journey begins with ejaculation, which delivers about 1.5 to 7 millilitres of semen into the upper vagina, near the cervix. A typical ejaculate holds 200 to 300 million sperm, though the WHO 2021 lower reference threshold for a fertile sample is just 39 million total sperm. The fluid is more than a carrier: seminal-vesicle secretions provide most of the volume and the fructose sperm burn for energy, while prostatic fluid adds enzymes and a slightly alkaline pH to buffer the acidic vagina.

Immediately after ejaculation, semen forms a thick gel-like coagulum that holds sperm near the cervix and prevents leakage. Over the next 20 to 30 minutes, enzymes in the prostatic fluid (mainly prostate-specific antigen, PSA) liquefy it and release the sperm. Failure to liquefy is one male-factor issue picked up on a semen analysis at an Indian NABL lab (roughly Rs 500 to Rs 2,000), and it can mechanically trap sperm before they ever enter the cervix.

The vagina itself is hostile territory. Its normal pH sits between 3.8 and 4.5, kept acidic by lactobacilli producing lactic acid. This acidity protects against infection but is lethal to sperm, which need a near-neutral environment to function. The alkaline buffer in semen briefly neutralises the area near the cervix for about 20 to 30 minutes, opening a short escape window.

Sperm that fail to reach the cervix in that window are essentially doomed; the pH swings back to acidic and kills them. Within an hour, the vast majority of deposited sperm have either entered the cervix or died. This is the first great bottleneck, and one reason an ejaculate carries hundreds of millions when only one is needed: the journey culls almost everything.

Propulsion in the vagina is mostly the sperm's own flagellar swimming, helped by anatomy: the cervix sits at the deepest point of the vagina and its opening usually points slightly downward, which suits sperm swimming upward. Female orgasm has been hypothesised to assist transport through uterine contractions, but the evidence is mixed and orgasm is not necessary for conception.

Position during and after sex is the subject of endless TTC myth. Honestly, position does not meaningfully change conception odds for couples with normal anatomy; sperm swim against gravity easily and the cervix sits high in any standard position. Lying down for 10 to 15 minutes afterwards may marginally help retention, but the effect is small. The far bigger lever is timing intercourse to the fertile window.

Lubricants matter more than position. Most common products, including KY Jelly, Durex Play and Manforce, are glycerol- or silicone-based and toxic to sperm, sharply reducing motility and survival. Couples actively trying should use no lubricant or sperm-friendly options such as Pre-Seed (Rs 600 to 1,500) or Conceive Plus (Rs 800 to 1,800), available on Tata 1mg, PharmEasy and Amazon. Your own fertile cervical mucus near ovulation is the ideal lubricant and actively supports sperm survival, which is part of why fertile-window timing matters.

The cervix is the gateway to the upper tract and the second major checkpoint. Its canal is lined with hundreds of small crypts (folds and pockets) and produces mucus that changes dramatically across the cycle under estrogen and progesterone.

Outside the fertile window, cervical mucus is thick, sticky, opaque and acidic. Its tight mesh is nearly impassable and its low pH is hostile to sperm. This is the normal infertile-phase mucus that exists for most of the cycle, acting as both a physical and chemical barrier, and also blocking infections from ascending into the uterus.

In the days before ovulation, rising estrogen transforms it into fertile, egg-white cervical mucus (EWCM), so named for its resemblance to raw egg white. Fertile mucus is clear, slippery, stretchy, abundant and slightly alkaline. Its mesh opens into microscopic channels that protect, nourish and orient sperm, while the pH and glucose content support survival. Learning to read this mucus is one of the most useful, free fertility skills.

Crucially, fertile mucus also acts as a sperm reservoir. Sperm that enter the crypts during the fertile window can be stored for up to five days and released slowly into the uterus and tubes. This survival of sperm in the female tract is the biological basis of the famous five-day fertile window, and it is why intercourse two or three days before ovulation often works as well as, or better than, intercourse on ovulation day itself.

Mucus quality is a real female-factor variable. Some women have consistently scant or hostile mucus despite normal ovulation. Causes include prior cervical surgery (LEEP, cone biopsy), antihistamines, clomiphene (which has anti-estrogen effects on mucus), and idiopathic poor quality. The old postcoital test is no longer routinely recommended by ASRM.

For couples trying to conceive, optimise mucus during the fertile window: stay well hydrated, avoid drying antihistamines around ovulation, and time intercourse to the days of best, stretchiest mucus. The shift to slippery EWCM typically appears two to four days before ovulation.

In assisted reproduction the mucus barrier is bypassed entirely. In intrauterine insemination (IUI), prepared sperm is placed directly into the uterus through a fine catheter; in IVF, egg and sperm meet in the lab. This is one reason these treatments can succeed where a cervical-mucus problem has blocked natural conception.

Once sperm enter the cervix and its crypts, they move upward into the uterus, helped by uterine peristalsis, rhythmic contractions that sweep from the cervix toward the tubes during the fertile window. These contractions are influenced by prostaglandins in semen and by oxytocin, and they create a current that ferries sperm across the cavity.

The uterus is also selective. White blood cells in the cavity attack damaged or abnormal sperm as part of the immune response to foreign cells, eliminating a substantial fraction so that mainly healthy sperm continue toward the tubes.

Transit time varies. The fastest sperm carried by efficient peristalsis can cross the uterus in minutes, reaching the entrance to the fallopian tubes (the utero-tubal junction) within the first hour. Slower sperm, especially those released gradually from cervical crypts over the following days, take far longer.

The utero-tubal junction is another filter, narrow and lined with cilia and crypts. Only the most normal, motile sperm pass efficiently. By the time sperm reach the tubes, the population has been winnowed from the original 200 to 300 million down to a few thousand, and only a few hundred typically reach the upper tube where the egg waits.

Structural problems can impair this transit: endometrial polyps, fibroids that distort the cavity, and adhesions from prior surgery (Asherman syndrome). The cavity is assessed in a fertility workup using saline infusion sonography (SIS), hysterosalpingography (HSG) or office hysteroscopy. Treatment depends on the finding, for example hysteroscopic polypectomy (around Rs 25,000 to 60,000 at Indian centres).

Uterine contractility also matters and varies between women and across the cycle. Excessive contractility, sometimes seen with adenomyosis or severe dysmenorrhea, can hinder rather than help sperm transport, though the evidence is mixed. Adenomyosis is increasingly recognised as fertility-relevant and can be evaluated by transvaginal ultrasound and MRI.

The uterine environment stays critical after fertilisation, because the embryo must implant into the endometrium about 6 to 12 days after ovulation. Receptivity depends on adequate progesterone from the corpus luteum, adequate endometrial thickness (typically above 7 to 8 mm at ovulation) and correct molecular signalling. Failure of any step can cause implantation to fail even after a normal sperm-egg union.

The fallopian tubes connect uterus to ovaries and are the actual site of fertilisation. Each is about 10 to 12 cm long, divided into the intramural segment (inside the uterine wall), the isthmus (narrow inner section), the ampulla (wider middle section where fertilisation usually occurs) and the infundibulum (the open outer end with finger-like fimbriae that catch the egg).

After passing the utero-tubal junction, sperm swim through the isthmus toward the ampulla. The tube lining is covered with cilia that beat in coordinated waves; around ovulation they beat toward the uterus to move the egg inward. Sperm therefore swim against this current, one more reason most never arrive.

The tube also stores sperm. Those reaching the isthmus can wait in small reservoirs for several days. Combined with cervical-crypt storage, this creates a relay of sperm reservoirs along the tract, which is why intercourse a few days before ovulation can still result in conception.

The egg, released at ovulation, is captured by the fimbriae and swept into the ampulla. It is the largest single cell in the body, about the size of a grain of sand. Its fertilisable lifespan is short, only 12 to 24 hours, after which it degenerates. This brief window is exactly why the fertile period extends far more in the days before ovulation (when sperm can wait) than after it.

Before they can fertilise anything, sperm must complete two maturation steps. Capacitation, chemical changes to the sperm membrane that begin once sperm enter the cervix, takes several hours; an uncapacitated sperm cannot fertilise even if it reaches the egg. Then hyperactivation changes the flagellar beat from smooth swimming to a whip-like motion powerful enough to push through the cumulus oophorus and the zona pellucida. This is why a sperm that reaches the egg in 30 to 45 minutes may still need hours before it can do anything.

When a capacitated, hyperactivated sperm reaches the egg, it undergoes the acrosome reaction, releasing enzymes that digest a path through the zona pellucida. The first sperm to fuse with the egg membrane triggers the zona reaction, which hardens the coat and blocks any other sperm, the polyspermy block that ensures only one sperm fertilises each egg.

After fusion, the sperm's chromosomes enter the egg. Over the next 12 to 18 hours the egg finishes its arrested meiotic division, the two pronuclei move together and fuse, forming a diploid zygote. That fusion is fertilisation in the strict sense. The zygote then divides as cilia and peristalsis carry it back through the isthmus into the uterus over 4 to 5 days, arriving as a blastocyst of 100 to 200 cells ready to implant. Damage or blockage of the tubes, from prior pelvic infection, endometriosis, surgery or congenital causes, can interfere with any of these steps and is a common cause of female-factor infertility.

The numbers are striking and worth understanding, because they explain why male factor matters, why timing matters, and why the 'just one sperm' folk wisdom is misleading.

An average ejaculate holds 200 to 300 million sperm (anywhere from 39 million to over 500 million can be normal per WHO 2021). Of these, perhaps half are motile and around 30% progressively motile. Normal morphology is only about 4% or more under strict Kruger criteria used by modern Indian andrology labs. So from the start, perhaps 5 to 10 million sperm are both progressively motile and normally shaped, the ones actually capable of the journey.

From there the attrition is steep. Most die in the acidic vagina within an hour. Perhaps a million enter the cervix, many of them filtered or held in crypts. Perhaps 100,000 to 200,000 swim into the uterus over the following hours. The uterine immune attack and the utero-tubal junction filter further. By the tubes, perhaps 1,000 to 10,000 remain; at the ampulla where the egg waits, only a few hundred.

On speed: the fastest sperm, carried by efficient peristalsis, reach the ampulla within 30 to 45 minutes. Average sperm swimming under their own power take several hours. The slowest, released gradually from cervical crypts, may take a day or more.

Survival depends entirely on environment. In acidic vaginal pH most sperm die within an hour; in hostile non-fertile mucus within a few hours; in fertile EWCM they survive 3 to 5 days, with rare survival up to 7. In the uterus and tubes they typically last 24 to 72 hours. This integrated survival is the basis for the five-day fertile window.

The egg's window is much shorter, just 12 to 24 hours, which is why the fertile period stretches backward (sperm can wait) rather than forward. Practically, intercourse in the two days before ovulation is peak fertility, with a per-act conception probability of roughly 25 to 35% in healthy young couples. Ovulation day itself is fertile but slightly less so, because fresh sperm have only a brief window left to mature and arrive.

Per-cycle conception probability in healthy fertile couples with well-timed intercourse is 25 to 30%, the foundational fertility statistic. Cumulatively, about 60 to 65% conceive within 3 months, 80 to 85% within 6 months and 85 to 90% within 12 months in couples under 35. Because conception probability falls steadily with age, couples who have not conceived within 12 months (or 6 months if the woman is 35 or older) should consider evaluation, the standard threshold per ASRM, ESHRE, NICE NG73 and FOGSI.

These numbers also show why both partners matter. A man with severely low count, motility or morphology may simply not have enough sperm completing the journey. A woman with hostile mucus, tubal blockage, ovulation problems or endometrial issues can stall the female-side requirements. Every link in the chain counts, and weakness at any one can reduce or eliminate conception.

Fertilisation is not the end; it is the start of a multi-day developmental and transport journey ending in implantation. Understanding this is why pregnancy tests are unreliable until at least 10 to 14 days after ovulation.

Within 24 hours the zygote completes its first division into a 2-cell embryo. Divisions continue: roughly 4 cells by 36 hours, 8 cells by 60 hours, the solid morula by about 4 days, and the fluid-filled blastocyst by about 5 days, by which point it has reached the uterus.

Throughout these divisions the embryo is carried from the ampulla, through the isthmus and into the uterine cavity by ciliary action and tubal peristalsis, arriving around 4 to 5 days after fertilisation.

It then develops for another 1 to 3 days before implanting. Implantation typically occurs 6 to 12 days after ovulation, most commonly day 8 to 10. The blastocyst hatches from the zona pellucida, and the outer trophectoderm cells invade the endometrium to begin forming the placental connection.

Implantation success depends on several things at once: an adequately thick endometrium (typically above 7 to 8 mm) in the right progesterone-driven secretory phase, a developmentally normal embryo, and coordinated molecular signalling. Failure of any one leads to implantation failure, where the embryo is shed without a clinical pregnancy. Very early failures are usually imperceptible and are part of why per-cycle rates sit well below 100% even in fertile couples.

Once implantation begins, trophectoderm cells produce human chorionic gonadotropin (hCG), the hormone pregnancy tests detect. hCG enters the bloodstream, tells the corpus luteum to keep making progesterone, and rises rapidly, roughly doubling every 48 to 72 hours.

The timing of detection reflects how long hCG takes to rise. Sensitive home tests at 10 mIU/mL (FirstResponse Early Result, Clearblue Early Detection) can detect pregnancy from 10 to 12 days after ovulation in some women. Standard 25 mIU/mL tests (i-can, Velocit, Prega News) reliably detect it from about 14 days, around the expected period. Blood beta-hCG at NABL labs (Rs 300 to 800) is even more sensitive. Our guide to the two-week wait covers exactly when and how to test without driving yourself mad.

The corpus luteum then keeps producing progesterone beyond its usual lifespan until the placenta takes over through the luteoplacental shift, completing around 7 to 10 weeks. This is the basis for continuing luteal-phase progesterone through 8 to 10 weeks in IUI and IVF cycles.

If implantation never occurs or fails very early, hCG stays undetectable, the corpus luteum runs its programmed 12 to 14 day lifespan and degenerates, progesterone falls and the endometrium sheds as a period. In healthy fertile couples this happens 70 to 75% of cycles even with perfect timing, which is normal biology, not dysfunction.

Many factors shape the speed and success of the journey from ejaculation to fertilisation. Understanding them helps couples optimise their chances and recognise when evaluation is warranted.

Sperm quality is the most direct factor. Count, motility, morphology and DNA integrity all affect how many sperm complete the journey and whether they can fertilise. A semen analysis at an NABL lab (SRL, Metropolis, Apollo Diagnostics, Thyrocare, Dr Lal PathLabs; Rs 500 to 2,000) is the standard test. Per WHO 2021, a normal sample shows volume above 1.4 mL, total count above 39 million, concentration above 16 million/mL, total motility above 42%, progressive motility above 30% and normal morphology above 4%. The full picture is covered in our guide to male factor infertility.

Male lifestyle factors that lower sperm quality include smoking, excessive alcohol, recreational drugs, obesity (raising the estrogen-to-androgen ratio), and scrotal heat (saunas, hot tubs, laptops on the lap, tight underwear). Some medications, including anabolic steroids and certain chemotherapy agents, also impair production. Because the spermatogenesis cycle runs about 70 to 90 days, improvements take roughly three months to show.

Female cervical mucus quality affects transport and survival; hostile or scant mucus impedes entry, while fertile EWCM supports it. Tubal patency matters too: damage from prior pelvic inflammatory disease, endometriosis or surgery can block transport or trap an embryo in the tube, causing ectopic pregnancy. An HSG (Rs 2,500 to 6,000 at Indian centres) assesses tubal patency. Uterine factors such as polyps, fibroids or adhesions can be evaluated with SIS or hysteroscopy.

Timing relative to ovulation is the single largest couples-controllable variable. The fertile window runs the 5 days before ovulation through ovulation day, with peak fertility in the 2 days just before. Track ovulation through cervical mucus (free, needs practice), basal body temperature (retrospective confirmation), or LH-based ovulation kits (i-can Rs 80 to 150 per strip, Inito Rs 7,000 to 12,000), or follicular monitoring scans at a clinic.

Frequency also matters: intercourse every 1 to 2 days through the fertile window is optimal, and daily intercourse is fine in fertile men without meaningfully depleting count. Saving up through long abstinence does not improve quality and may slightly reduce it. Lubricant choice matters significantly, as covered above, with sperm-friendly products or none being best.

Overall health and stress affect both partners. Severe stress can disrupt ovulation and spermatogenesis. Good nutrition, adequate sleep, moderate exercise, a healthy weight (BMI 18.5 to 25, or 18.5 to 23 by Asian-Indian cut-offs), avoiding smoking and excess alcohol, and managing diabetes, thyroid disorders and PCOS all support fertility, as does an evidence-based fertility diet. Finally, age affects both sides: female fertility declines from the mid-30s, and male fertility declines more gradually from the late 30s, with effects on DNA quality and miscarriage risk.

If a couple has been trying without success, evaluating the male partner is essential. Male factor accounts for roughly 40% of Indian fertility issues per ICMR data, comparable to or higher than female factor in many populations. Yet male evaluation is often delayed in Indian practice, partly through cultural reluctance and partly through a historical female-first focus. The evidence-based approach is to evaluate both partners simultaneously from the start.

The semen analysis is the first-line male test (Rs 500 to 2,000 at NABL labs across metros and tier-2 cities). The sample is usually collected at the lab after 2 to 7 days of abstinence; some labs allow home collection if delivered within an hour at body temperature. Results report volume, concentration, total count, motility, morphology, vitality, white-cell count and pH.

Per WHO 2021, normal parameters are volume above 1.4 mL, total count above 39 million, concentration above 16 million/mL, total motility above 42%, progressive motility above 30%, vitality above 54% and normal morphology above 4% (strict Kruger). Any single abnormal result should be repeated after 6 to 12 weeks, because the spermatogenesis cycle is 70 to 90 days and a repeat assesses a fresh sperm cohort, before drawing conclusions.

Abnormal patterns have specific names. Oligozoospermia is low count, asthenozoospermia low motility, teratozoospermia abnormal morphology, and OAT the common combination of all three. Azoospermia is absence of sperm, necrozoospermia a high proportion of dead sperm, and aspermia no ejaculate.

Further evaluation follows the findings. Mild to moderate oligozoospermia or asthenozoospermia is first managed with lifestyle change and a repeat test in 3 to 6 months. Severe oligozoospermia (below 5 million/mL) warrants genetic testing for Y-chromosome microdeletions (AZF) and karyotype. Azoospermia needs the obstructive-versus-non-obstructive distinction, using FSH, testosterone, scrotal ultrasound and sometimes testicular biopsy.

DNA Fragmentation Index (DFI) testing assesses sperm DNA integrity and is used selectively in unexplained infertility, recurrent pregnancy loss or repeated IVF failure (Rs 5,000 to 15,000). High DFI is linked to reduced fertility and higher miscarriage risk; lifestyle change, antioxidants and, in some cases, IVF with ICSI using selected sperm can help.

Andrology specialists in India cluster at major fertility centres including Nova IVF Fertility, Cloudnine and Birla Fertility, plus standalone clinics in Mumbai, Bengaluru, Delhi-NCR, Hyderabad, Chennai and Pune. Treatment depends on cause: hormonal causes are treated with hormone therapy, varicocele can be repaired surgically in selected cases, obstructive azoospermia is addressed with surgical sperm retrieval (TESA, PESA, micro-TESE) plus IVF/ICSI, and non-obstructive azoospermia is more challenging, with micro-TESE giving the best retrieval rates. Unexplained or untreatable male factor is managed with assisted reproduction, IUI for mild cases and IVF with ICSI for moderate to severe.

Costs in India are generally favourable: semen analysis Rs 500 to 2,000, AZF and DFI Rs 5,000 to 15,000 each, andrology consultation Rs 500 to 2,500, varicocele repair Rs 30,000 to 80,000, and micro-TESE Rs 75,000 to 2 lakh. Most are out of pocket, as Indian health insurance rarely covers fertility evaluation or treatment, though some employer benefits and premium plans offer partial cover.

Indian fertility care operates within a specific regulatory, clinical and cultural context that shapes how this conversation plays out in practice.

FOGSI (Federation of Obstetric and Gynaecological Societies of India) and ISAR (Indian Society for Assisted Reproduction) are the two main professional bodies. FOGSI publishes position statements on evaluation, ovulation induction, IUI and IVF that blend international evidence with Indian realities; ISAR focuses on ART procedures and laboratory standards. Both emphasise timing optimisation, lifestyle change and structured evaluation over rushing to high-cost interventions.

ICMR provides government-level guidance and maintains the National Registry of ART Clinics and Banks under the ART Act 2021. The Act sets standards for accreditation, embryologist qualifications, consent, age limits (women up to 50, men up to 55) and outcome reporting; all clinics offering ART must be registered.

Male evaluation has historically been delayed by cultural reluctance to view the male partner as a source of difficulty, but this has shifted markedly over the last decade. With male factor at roughly 40% per ICMR, modern chains including Nova IVF, Cloudnine, Indira IVF, Bloom IVF and Birla Fertility now routinely evaluate both partners from the first visit, and FOGSI specifically recommends simultaneous evaluation rather than female-first sequencing.

Cultural pressure on married couples to conceive quickly is real. Joint-family structures and extended-family expectations can be emotionally damaging for couples who do not conceive in the first few months, and may push them toward evaluation earlier than the standard threshold. Couples can certainly be evaluated earlier if they prefer, but the threshold for active intervention should rest on medical criteria, not family pressure. Our guide to the emotional journey of trying to conceive covers staying connected through this phase.

Religious and ethical views affect some decisions around donor gametes, surrogacy or genetic testing. Specialists in major centres are generally experienced in navigating these sensitively, and most chains have counsellors. The ART Act 2021 and the Surrogacy (Regulation) Act 2021 set the legal boundaries in India.

Geographic access varies. Metros (Mumbai, Bengaluru, Delhi-NCR, Hyderabad, Chennai, Pune, Kolkata) have extensive options; tier-2 cities (Ahmedabad, Surat, Jaipur, Lucknow, Bhopal, Indore, Coimbatore, Kochi, Nagpur) have growing options; tier-3 and rural areas have more limited access, though chains like Indira IVF have expanded aggressively into smaller cities. Government tertiary hospitals (AIIMS, KEM, JIPMER, PGIMER, state medical colleges) offer evaluation and some ART at subsidised cost, though waiting lists are long. PMJAY generally does not cover fertility treatment, though some state schemes provide partial cover.

Dietary and lifestyle factors interact with the journey. The high refined-carbohydrate Indian diet contributes to insulin resistance and PCOS in women and to metabolic dysfunction and reduced sperm quality in men. Vitamin D deficiency is very common given indoor lifestyles and sun avoidance, and supplementation may modestly help in deficient individuals. B12 deficiency, common in vegetarian populations, can affect sperm quality. FOGSI and ICMR preconception guidance addresses these alongside the universal advice on folic acid, iron, calcium and balanced nutrition.

Translating all this biology into practice produces a clear set of action items that maximise the chance of sperm and egg meeting successfully. Our broader trying-to-conceive guide ties these together.

First, identify the fertile window accurately. The most common TTC mistake is assuming day-14 ovulation in cycles that are not 28 days. Ovulation usually occurs about 14 days before the next period, not 14 days after the last one, so in a 30-day cycle it is around day 16, in a 32-day cycle around day 18, and in a 25-day cycle around day 11. Track several cycles or use ovulation kits to detect the LH surge that precedes ovulation by 24 to 36 hours.

Second, time intercourse to that window. The five-day window covers the five days before ovulation and ovulation day, with peak fertility in the two days just before. Intercourse every 1 to 2 days through the window is optimal; daily is also fine. Avoid the common trap of saving sex for 'the right day' and missing the window.

Third, use cervical mucus observation alongside or instead of kits. Fertile EWCM, clear, stretchy and slippery, usually appears two to four days before ovulation and is the most direct sign of fertility. Combining mucus and LH-kit tracking is more accurate than either alone.

Fourth, avoid sperm-toxic lubricants. KY Jelly, Durex Play and Manforce significantly impair sperm; use Pre-Seed (Rs 600 to 1,500), Conceive Plus (Rs 800 to 1,800) or no lubricant and rely on natural EWCM.

Fifth, optimise health on both sides. Avoid smoking, limit alcohol, keep a healthy weight (BMI 18.5 to 25, or 18.5 to 23 for Asian-Indian cut-offs), exercise moderately, eat well and manage chronic conditions. The male partner should avoid scrotal heat and remember that sperm improvements take about 70 to 90 days.

Sixth, take preconception folic acid. The female partner should take 400 to 800 mcg daily from at least three months before conceiving (Folvite Rs 30 to 80/month, or a prenatal multivitamin at Rs 200 to 800/month). Higher doses (4 to 5 mg) apply for a prior neural-tube-defect pregnancy, certain anti-epileptics, diabetes or BMI 30+. See our guide to folic acid before conception.

Seventh, evaluate at the right time, 12 months of well-timed intercourse without conception under 35, or 6 months at 35 and over. Evaluate earlier with specific risk factors (irregular cycles outside 24 to 35 days, PCOS, thyroid issues, prior pelvic surgery or PID, known male factors, low AMH, age 40+). Both partners should be evaluated together.

Eighth, manage the emotional load. The two-week wait, monthly disappointment, family pressure and cost all weigh heavily. Plan support: partner communication, friends with shared experience, fertility-focused therapists (Rs 1,000 to 3,000/session) and free helplines such as iCall (9152987821) and Vandrevala Foundation (1860-2662-345).

Ninth, set a realistic horizon. Per-cycle probability is 25 to 30%, with cumulative rates of 60 to 65% at three months, 80 to 85% at six and 85 to 90% at twelve. Most cycles will not result in pregnancy even with perfect timing and normal fertility. That is biology, not failure, and naming it honestly helps couples persist through the inevitable disappointments.

• You have had regular, well-timed intercourse for 12 months without conceiving (or 6 months if the woman is 35 or older).
• The woman has irregular cycles (outside 24 to 35 days), absent periods, known PCOS, thyroid disease, endometriosis, or a history of pelvic infection or surgery.
• There is a known or suspected male factor, such as a previous abnormal semen analysis, testicular surgery, undescended testes or low libido.
• Either partner is 40 or older, or the woman has a low ovarian reserve (AMH below 1.0 ng/mL).
• You have had two or more miscarriages, which warrants recurrent-pregnancy-loss evaluation regardless of how long you have been trying.
• Severe one-sided pelvic pain with a positive pregnancy test, shoulder-tip pain, dizziness or fainting: seek emergency care immediately, as this can signal an ectopic pregnancy.

• WHO laboratory manual for the examination and processing of human semen, 6th edition (2021)
• ACOG: Evaluating Infertility (FAQ)
• NICE Guideline NG73: Fertility problems — assessment and treatment
• American Society for Reproductive Medicine (ASRM): Optimizing natural fertility
• ICMR / National ART and Surrogacy (Regulation) Acts, 2021
• NHS: Trying to get pregnant